Leo Pharma loses US region CEO – interim replacement found in current CFO
![Photo: Leo Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13432191.ece/ALTERNATES/schema-16_9/doc7i9f7068znl1i61pf1yx.jpg)
Leo Pharma is waving goodbye to its former CEO of its US operations, Christopher Posner. Posner has left the company to join the US-listed biotech business Cara Therapeutics, where he has sat on the board.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
FDA fast tracks former Leo Pharma eczema candidate
For subscribers